CICOIRA, Mariantonietta
 Distribuzione geografica
Continente #
NA - Nord America 6.151
EU - Europa 5.193
AS - Asia 3.490
SA - Sud America 636
Continente sconosciuto - Info sul continente non disponibili 123
AF - Africa 110
OC - Oceania 8
AN - Antartide 1
Totale 15.712
Nazione #
US - Stati Uniti d'America 6.033
GB - Regno Unito 1.671
RU - Federazione Russa 1.657
SG - Singapore 1.563
CN - Cina 911
BR - Brasile 514
IT - Italia 348
FR - Francia 332
HK - Hong Kong 308
DE - Germania 280
VN - Vietnam 277
FI - Finlandia 240
IE - Irlanda 235
SE - Svezia 212
KR - Corea 125
UA - Ucraina 101
BD - Bangladesh 60
CA - Canada 52
IN - India 42
NG - Nigeria 40
AR - Argentina 34
TR - Turchia 30
MX - Messico 28
EC - Ecuador 24
ID - Indonesia 24
CO - Colombia 20
IQ - Iraq 20
ZA - Sudafrica 20
JP - Giappone 17
BE - Belgio 16
CL - Cile 15
NL - Olanda 15
AT - Austria 12
PH - Filippine 12
SA - Arabia Saudita 12
ES - Italia 11
MA - Marocco 11
PL - Polonia 11
UZ - Uzbekistan 11
IL - Israele 10
KE - Kenya 10
VE - Venezuela 9
EG - Egitto 8
LT - Lituania 8
MY - Malesia 8
PE - Perù 8
PK - Pakistan 8
ET - Etiopia 7
JM - Giamaica 7
JO - Giordania 7
OM - Oman 7
PY - Paraguay 7
AU - Australia 6
CR - Costa Rica 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
DO - Repubblica Dominicana 5
RO - Romania 5
CH - Svizzera 4
IR - Iran 4
NP - Nepal 4
PA - Panama 4
UY - Uruguay 4
BG - Bulgaria 3
CI - Costa d'Avorio 3
DK - Danimarca 3
DZ - Algeria 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LB - Libano 3
MD - Moldavia 3
PS - Palestinian Territory 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
BY - Bielorussia 2
DM - Dominica 2
EU - Europa 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
LV - Lettonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
TH - Thailandia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BZ - Belize 1
Totale 15.574
Città #
Southend 1.516
Singapore 814
Jacksonville 811
Woodbridge 581
Ashburn 533
Chandler 509
San Jose 480
Moscow 444
Dallas 412
Ann Arbor 333
Hong Kong 301
Houston 257
Dublin 234
The Dalles 194
Verona 191
Council Bluffs 176
Beijing 164
Lawrence 121
Princeton 121
Wilmington 98
Nanjing 89
Los Angeles 79
Ho Chi Minh City 78
Sindelfingen 66
Buffalo 63
Jinan 62
New York 56
São Paulo 54
Hanoi 51
Santa Clara 47
Abuja 38
Boardman 37
Shenyang 35
Columbus 33
Munich 33
Redondo Beach 33
Tianjin 33
Hebei 32
Milan 28
Changsha 27
Hangzhou 25
Helsinki 23
Zhengzhou 22
Dong Ket 20
Norwalk 20
Guangzhou 19
Nanchang 19
Taiyuan 18
Chicago 17
Brasília 16
Brussels 16
Ningbo 16
Frankfurt am Main 15
Brooklyn 14
Fairfield 14
Montreal 14
Rio de Janeiro 14
Taizhou 14
Haikou 13
Haiphong 13
Jiaxing 13
Turku 13
Jakarta 12
Tokyo 12
Toronto 12
Stockholm 11
Biên Hòa 10
Düsseldorf 10
Falkenstein 10
Fuzhou 10
London 10
Seattle 10
Tashkent 10
Belo Horizonte 9
Bologna 9
Guayaquil 9
Lancaster 9
Nairobi 9
Nuremberg 9
San Francisco 9
Washington 9
Boston 8
Buenos Aires 8
Da Nang 8
Denver 8
Johannesburg 8
Lanzhou 8
Shanghai 8
Warsaw 8
Addis Ababa 7
City of London 7
Dhaka 7
Mexico City 7
Orem 7
Phoenix 7
Rome 7
Amman 6
Auburn Hills 6
Campinas 6
Curitiba 6
Totale 9.958
Nome #
Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group 719
Cardiorenal Syndrome Type 1: Pathophysiological Crosstalk Leading to Combined Heart and Kidney Dysfunction in the Setting of Acutely Decompensated Heart Failure. 236
Aortic and mitral annular calcification are predictive of all-cause and cardiovascular mortality in patients with type 2 diabetes. 235
Aortic stiffness correlates with an increased extracellular matrix turnover in patients with dilated cardiomyopathy. 214
Aortic distensibility independently affects exercise tolerance in patients with dilated cardiomyopathy. 207
Additional value of pulmonary vein parameters in defining pseudonormalization of mitral inflow pattern. 183
Alterazioni muscolari e intolleranza allo sforzo nello scompenso cardiaco congestizio: ruolo centrale della periferia 181
Increased aortic pulse wave velocity as measured by echocardiography is strongly associated with poor prognosis in patients with heart failure. 179
A higher body mass index is associated with reduced prevalence of unstable atherosclerotic plaque: A possible explanation of the obesity paradox. 175
Beta-blockers can improve survival in medically-treated patients with severe symptomatic aortic stenosis 175
Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle. 174
Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. 172
Biventricular pacing. 170
Determinants of exercise intolerance symptoms considered non-specific for heart failure in patients with stage A and B: role of the left atrium in the transition phase to overt heart failure 169
Relationship between mitral regurgitation and myocardial viability after acute myocardial infarction: their impact on prognosis 166
The role of angiotensin-converting enzyme polymorphism in congestive heart failure. 164
Association of deranged adrenal steroid metabolism with anemia in chronic heart failure. 164
Body mass index, prognosis and mode of death in chronic heart failure: Results from the Valsartan Heart Failure Trial. 162
Echocardiographically Derived Pulse Wave Velocity and Diastolic Dysfunction Are Associated with an Increased Incidence of Atrial Fibrillation in Patients with Systolic Heart Failure 161
Aortic valve sclerosis: a marker of significant obstructive coronary artery disease in patients with chest pain? 160
Aortic valve sclerosis is a marker of atherosclerosis independently of traditional clinical risk factors. Analysis in 712 patients without ischemic heart disease. 158
Left Atrial Volume Provides Independent and Incremental Information Compared With Exercise Tolerance Parameters in Patients With Heart Failure and Left Ventricular Systolic Dysfunction. 157
Echocardiographic advances in hypertrophic cardiomyopathy: Three-dimensional and strain imaging echocardiography 157
Amino-terminal propeptide of type III procollagen is associated with restrictive mitral filling pattern in patients with dilated cardiomyopathy: a possible link between diastolic dysfunction and prognosis. 156
Predicting heart failure outcome from cardiac and comorbid conditions: The 3C-HF score. 153
Skeletal muscle mass independently predicts peak oxygen consumption and ventilatory response during exercise in noncachectic patients with chronic heart failure. 152
Left atrial overload can be used to estimate mitral regurgitant volume. 150
Mitral regurgitation and dyspnoea: The expanding role of mitral effective regurgitant orifice among un-selected patients 149
Growth hormone resistance in chronic heart failure and its therapeutic implications. 147
Aortic distensibility independently affects exercise tolerance in patients with dilated cardiomyopathy 146
Aortic stiffness: an old concept for new insights into the pathophysiology of functional mitral regurgitation. 146
Association of aortic valve sclerosis and coronary artery disease in patients with severe nonischemic mitral regurgitation. 144
Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. 143
Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure. 141
ESPEN Guidelines on Enteral Nutrition: Cardiology and pulmonology. 141
Ambient air pollution as a new risk factor for cardiovascular diseases: Time to take action 139
Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients 137
Impact of body mass index on short-term outcome after acute myocardial infarction: does excess body weight have a paradoxical protective role? 137
Functional mitral regurgitation in patients with aortic stenosis: prevalence, clinical correlates and pathophysiological determinants: a quantitative prospective study. 137
Relevance of Functional Mitral Regurgitation in Aortic Valve Stenosis 137
Fill in the Gaps of Secondary Mitral Regurgitation: a Continuum Challenge From Pathophysiology to Prognosis 137
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation. 136
Chronic heart failure and cardiac cachexia and links between the endocrine and immune system 135
High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients. 135
Prognostic implications of evaluation of contractile reserve in akinetic and hypokinetic segments during low dose dobutamine echocardiography in patients with acute myocardial infarction. 135
Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy. 134
Mitral regurgitation, left atrial structural and functional remodelling and the effect on pulmonary haemodynamics 129
Carotid atherosclerotic plaque instability in patients with acute myocardial infarction. 128
Renal arterial pulsatility predicts progression of chronic kidney disease in chronic heart failure patients. 128
Identification of High-Risk Chronic Heart Failure Patients in Clinical Practice: Role of Changes in Left Ventricular Function. 127
Role of growth hormone in chronic heart failure: therapeutic implications 126
Echocardiographic determinants of mortality in patients 67 years of age with chronic heart failure 126
Myocardial viability independently influences left ventricular diastolic function in the early phase after acute myocardial infarction. 126
Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype 123
Relation of aldosterone "escape" despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. 123
Mitral regurgitation and left ventricular diastolic dysfunction similarly affect mitral and pulmonary vein flow Doppler parameters: the advantage of end-diastolic markers. 122
Inhibitors of angiotensin-converting enzyme and physical function in older women. 121
Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia 121
Role of growth hormone in chronic heart failure 120
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study 120
Uric acid and survival in chronic heart failure: validation and application in metabolic, functional and hemodynamic staging. 118
Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients. 118
Outpatients electrical cardioversion of atrial fibrillation: 8 years' experience. Analysis of shock-related arrhythmias. 118
Growth hormone treatment in chronic heart failure: lessons from the first 99 patients 117
Chronic heart failure with preserved left ventricular ejection fraction: Diagnostic and prognostic value of left atrial size. 117
Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure. 117
Prognostic value of detection of myocardial viability using low-dose dobutamine echocardiography in infarcted patients 116
Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure. 115
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 115
Emerging strategies for chronic heart failure: the role of gene therapy 115
Long-term prognostic value of the stenosis of the infarct-related artery and the presence of viable myocardium in akinetic ventricular regions in infarcted patients 114
Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope. 111
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition. 111
Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy. 109
Exercise Performance Is a Prognostic Indicator in Elderly Patients With Chronic Heart Failure--Application of Metabolic Exercise Cardiac Kidney Indexes Score 109
Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not norepinephrine or TNF-alpha 108
Chronic heart failure in the very elderly: clinical status, survival and prognostic factors in 188 patients more than 70 years old 108
Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure. 107
Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration 105
Prediction of mortality in chronic heart failure from peak oxygen consumption adjusted for either body weight or lean tissue. 104
Heart failure in women treated with adjuvant trastuzumab fro breast cancer. 104
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 104
Role of clinical evaluation and functional testing in the tailored follow-up of chronic heart failure patients 102
Mitral and aortic valve sclerosis/calcification and carotid atherosclerosis: results from 1065 patients. 101
Obesity paradox in patients with aortic valve stenosis. Protective effect of body mass index independently of age, disease severity, treatment modality and non-cardiac comorbidities. 101
Heart failure and anemia: Effects on prognostic variables 100
Prognostic relevance of a non-invasive evaluation of right ventricular function and pulmonary artery pressure in patients with chronic heart failure. 99
Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis 99
Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure. 98
Prognostic utlity of growth differentiation factor-15 in patients with chronic heart failure 98
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison. 98
Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow. 97
The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure 97
Role of iron deficiency and anemia in cardio-renal syndromes. 96
Effects of ace gene insertion/deletion polymorphism on response to spironolactone in patients with chronic hearth failure. 95
Ischemic etiology of heart failure identifies patients with more severely impaired exercise capacity. 95
Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy. 95
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition. 95
Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure 95
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 94
Totale 13.860
Categoria #
all - tutte 55.995
article - articoli 55.995
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.990


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022454 0 0 18 29 17 28 10 46 23 30 66 187
2022/20231.590 143 119 192 254 156 359 13 119 157 10 46 22
2023/2024659 23 82 58 108 87 71 17 44 3 18 108 40
2024/20252.196 150 162 46 358 75 77 133 114 303 164 146 468
2025/20265.409 448 307 446 837 1.239 356 649 326 324 217 138 122
2026/2027398 72 171 155 0 0 0 0 0 0 0 0 0
Totale 15.712